The completion of this ambitious project further demonstrates Takeda's transition into a truly global business, and strategic investment into key emerging markets such as Russia is a major part of this strategy. said Yasuchika Hasegawa, President & Chief Executive Officer of Takeda Pharmaceutical Company Limited.